Render Target: STATIC
Render Timestamp:
3/28/2025, 7:24:30 AM EDT
3/28/2025, 11:24:30 AM UTC
Commit: 461ca8d8fe5b1efd4c01fc87e5b5eb592e2d154a
XML generation date: 2025-03-07 13:16:58.746
Product last modified at: 2025-01-01T09:02:09.124Z
Cell Signaling Technology Logo
1% for the planet logo
PDP - Template Name: Chemical Modulators
PDP - Template ID: *******c501c72

TAK-242 #75523

    Product Information

    Product Usage Information

    TAK-242 is supplied as a lyophilized powder. For a 10 mM stock, reconstitute 5 mg of powder in 1.38 mL of DMSO. Working concentrations and length of treatment can vary depending on the desired effect.

    Storage

    Store lyophilized at -20ºC, desiccated. In lyophilized form, the chemical is stable for 24 months. Once in solution, store at -20ºC and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

    Product Description

    Molecular Weight 361.82 g/mol
    Purity >98%
    Molecular Formula C15H17ClFNO4S
    CAS 243984-11-4
    Solubility Soluble in DMSO at 100 mg/mL.

    Background

    TAK-242 is a small-molecule that specifically inhibits Toll-like receptor 4 signaling through binding to the intracellular domain of TLR4 at Cys747 (1). TLR4 triggers activation of the NF-κB, IRF-3, and MAPK pathways, leading to production of inflammatory cytokines. TAK-242 inhibits binding between TLR4 and adaptor molecules, including Toll/interleukin-1 (IL-1) receptor domain-containing adaptor protein (TIRAP), which blocks activation of NF-κB and other downstream signaling events (2). In LPS-stimulated mouse macrophages, TAK-242 suppressed the production of NO and the inflammatory cytokines tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) (3). In a study of LPS-induced myotube atrophy, TAK-242 provides a protective effect by inhibiting TLR4 and suppressing TNF-α- and IL-6-mediated inflammatory responses. Similar results were seen in a mouse model of endotoxemia, with TAK-242 inhibiting activation of inflammatory and proteolytic pathways and reversing the muscle wasting impact induced by LPS treatment (4).
    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.